Scientific background:

Summary: Mutations in LRP2 gene cause autosomal recessive Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).

Methodology:

	clinical test	Method		Genomic sequencing of the entire coding region
		Turn-around time		25 working days
		Effort		large
		Specimen		DNA
		Quality assessment		Internal quality control only
	All known and new missense, nonsense and splice mutations can be detected.
	clinical test	Method		Carrier testing
		Turn-around time		5 working days
		Effort		little
		Specimen		DNA
		Quality assessment		Internal quality control only
	The test is only specific about the mutation already known in this kindred.

Literature: 

et al. ()
Caruso-Neves C et al. (2006) PKB and megalin determine the survival or death of renal proximal tubule cells.
Chassaing N et al. (2003) Donnai-Barrow syndrome: four additional patients.
Chatelet F et al. (1986) Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution.
Chowdhary BP et al. (1995) In situ hybridization mapping of a 500-kDa calcium-sensing protein gene (LRP2) to human chromosome region 2q31-->q32.1 and porcine chromosome region 15q22-->q24.
Devriendt K et al. (1998) Proteinuria in a patient with the diaphragmatic hernia-hypertelorism-myopia-deafness syndrome: further evidence that the facio-oculo-acoustico-renal syndrome represents the same entity.
Donnai D et al. (1993) Diaphragmatic hernia, exomphalos, absent corpus callosum, hypertelorism, myopia, and sensorineural deafness: a newly recognized autosomal recessive disorder?
Farquhar MG et al. (1995) The unfolding story of megalin (gp330): now recognized as a drug receptor.
Farquhar MG et al. (1995) The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Hammes A et al. (2005) Role of endocytosis in cellular uptake of sex steroids.
Hjälm G et al. (1996) Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties.
Kantarci S et al. (2007) Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes.
Kerjaschki D et al. (1983) Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Korenberg JR et al. (1994) Chromosomal localization of human genes for the LDL receptor family member glycoprotein 330 (LRP2) and its associated protein RAP (LRPAP1).
Kounnas MZ et al. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin.
Leheste JR et al. (1999) Megalin knockout mice as an animal model of low molecular weight proteinuria.
Marinò M et al. (1999) Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis.
Moestrup SK et al. (1995) Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
Naccache SN et al. (2006) Binding of internalized receptors to the PDZ domain of GIPC/synectin recruits myosin VI to endocytic vesicles.
Nagai M et al. (2003) The adaptor protein ARH escorts megalin to and through endosomes.
Nykjaer A et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.
Nykjaer A et al. (2001) Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3).
Raychowdhury R et al. (1989) Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor.
Saito A et al. (1994) Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family.
Schmitz C et al. (2002) Megalin deficiency offers protection from renal aminoglycoside accumulation.
Tramontano A et al. (2004) Conformation and glycosylation of a megalin fragment correlate with nephritogenicity in Heymann nephritis.
Willnow TE et al. (1996) Defective forebrain development in mice lacking gp330/megalin.